Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Boutaud
Bertrand Boutaud, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20090021842 | METHOD OF MANUFACTURING AN ELECTROWETTING-BASED VARIABLE-FOCUS LENS - The present invention relates to a method of manufacturing an electrowetting-based variable-focus lens, comprising: (a) providing an enclosure having a cavity ( | 01-22-2009 |
| 20100149651 | VARIABLE-FOCUS LENS ASSEMBLY - The present invention relates to an electrowetting-based variable-focus lens comprising an enclosure with at least two components, an arrangement of first and second immiscible liquids ( | 06-17-2010 |
Bertrand Boutaud, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110230937 | Electrical Feedthrough In A Metal Wall Of A Housing Of An Active Medical Device And Method Of Making The Same - A method for making an hermetic and electrically insulating feedthrough in the metal wall of a housing of a device, preferably of an active medical device, is disclosed. The method includes: a) forming electrically insulating layers ( | 09-22-2011 |
Dominique Boutaud, Orleans FR
| Patent application number | Description | Published |
|---|---|---|
| 20100263222 | ZEOLITE DEHYDRATION UNIT - An installation for dehydrating products, the installation having an enclosure, a member for sucking out the air contained in the enclosure, and a container for products that is received inside the enclosure and that is provided with a top opening having an air- and water-permeable bottom of a cassette extending in register therewith. The cassette contains moisture-adsorption means. A sealing gasket extends between a perimeter of the bottom of the cassette and an edge of the container, defining the opening. | 10-21-2010 |
Olivier Boutaud, Nashville, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20080227776 | INHIBITORS OF HEMEPROTEIN-CATALYZED LIPID PEROXIDATION - Methods and compounds for the treatment or prevention of oxidative damage in a mammalian subject. The treatment and/or prevention may be on inhibiting heme-induced lipid peroxidation. Also discloses are methods and compounds for treating or preventing isoprostane-mediated tissue damage. | 09-18-2008 |
| 20100021938 | Diagnosis and Prediction of Alzheimer's Disease - Alzheimer's disease (AD) is characterized by the accumulation of amyloid-β peptide (Aβ) in the brain. Aβ is derived from amyloid precursor protein (APP) by β- and γ-secretases, with the β form (sAPPβ) being associated with the disease state, and the α form (sAPPα) being associated with the non-disease state. The present inventor proposes that defined the ratio of sAPPα to sAPPβ or the ratio of CTFα to CTFβ provide and accurate diagnosis of the disease, as well as a predictor for asymptomatic patients at risk of developing AD. In addition, drug screening and monitoring of treatment effectiveness can exploit this same sAPPα/sAPPβ or CTFα/CTFβ ratio. | 01-28-2010 |